Stay updated on UCART19 Dose Escalation Study in B-cell ALL Clinical Trial
Sign up to get notified when there's something new on the UCART19 Dose Escalation Study in B-cell ALL Clinical Trial page.

Latest updates to the UCART19 Dose Escalation Study in B-cell ALL Clinical Trial page
- Check4 days agoChange DetectedPage revision updated to v3.0.2 from v3.0.1; the 'Back to Top' link was removed. No substantive changes to core content, pricing, or timing.SummaryDifference0.2%
- Check11 days agoChange DetectedThe web page has been updated from version 3.0.0 to version 3.0.1, indicating a revision in the content.SummaryDifference0.2%
- Check18 days agoChange DetectedThe web page has updated its facility name and location details, specifically adding Paris, France, and information related to Precursor B-Cell Lymphoblastic Leukemia-Lymphoma, while removing several previous location references and related disease topics.SummaryDifference5%
- Check25 days agoNo Change Detected
- Check33 days agoChange DetectedThe web page has been updated from version 2.16.11 to version 2.16.12, indicating a revision in the content.SummaryDifference0.9%
- Check40 days agoChange DetectedThe web page has been updated from version 2.16.10 to version 2.16.11.SummaryDifference0.9%
- Check47 days agoChange DetectedThe web page has been updated to version 2.16.10, and a previous service alert regarding planned maintenance has been removed.SummaryDifference1%
Stay in the know with updates to UCART19 Dose Escalation Study in B-cell ALL Clinical Trial
Enter your email address, and we'll notify you when there's something new on the UCART19 Dose Escalation Study in B-cell ALL Clinical Trial page.